414 related articles for article (PubMed ID: 32604993)
1. Genetic Markers in Lung Cancer Diagnosis: A Review.
Wadowska K; Bil-Lula I; Trembecki Ł; Śliwińska-Mossoń M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32604993
[TBL] [Abstract][Full Text] [Related]
2. The significance of epigenetic alterations in lung carcinogenesis.
Brzeziańska E; Dutkowska A; Antczak A
Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers along the continuum of care in lung cancer.
Holdenrieder S
Scand J Clin Lab Invest Suppl; 2016; 245():S40-5. PubMed ID: 27542002
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and nonsmall cell lung cancer.
Lu F; Zhang HT
Anat Rec (Hoboken); 2011 Nov; 294(11):1787-95. PubMed ID: 21956844
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer epigenetics and genetics.
Risch A; Plass C
Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
[TBL] [Abstract][Full Text] [Related]
6. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
[TBL] [Abstract][Full Text] [Related]
7. The impact of genetic markers on the diagnosis of lung cancer: a current perspective.
Chorostowska-Wynimko J; Szpechcinski A
J Thorac Oncol; 2007 Nov; 2(11):1044-51. PubMed ID: 17975498
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in lung cancer.
Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
[TBL] [Abstract][Full Text] [Related]
9. [Molecular-genetic markers in lung cancer diagnostics].
Ponomareva AA; Rykova EIu; Cherdyntseva NV; Choĭnzonov EL; Laktionov PP; Vlasov VV
Mol Biol (Mosk); 2011; 45(2):203-17. PubMed ID: 21634110
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
[TBL] [Abstract][Full Text] [Related]
11. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy.
Frydrychowicz M; Kuszel Ł; Dworacki G; Budna-Tukan J
J Appl Genet; 2023 Sep; 64(3):459-477. PubMed ID: 36821071
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and lung cancers: from pathogenesis to clinical implications.
Qi J; Mu D
Front Med; 2012 Jun; 6(2):134-55. PubMed ID: 22528868
[TBL] [Abstract][Full Text] [Related]
14. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.
Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D
Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233
[TBL] [Abstract][Full Text] [Related]
16. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA as tools and therapeutics in lung cancer.
Barger JF; Nana-Sinkam SP
Respir Med; 2015 Jul; 109(7):803-12. PubMed ID: 25910758
[TBL] [Abstract][Full Text] [Related]
18. NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.
Zhou C; Qin Y; Xie Z; Zhang J; Yang M; Li S; Chen R
Biochem Biophys Res Commun; 2015 Mar; 458(2):381-6. PubMed ID: 25646694
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in lung cancer diagnosis and therapy.
Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
[TBL] [Abstract][Full Text] [Related]
20. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
